This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

EP Global Communications, Inc. Announces Major Development And Fact Sheet For EP Investors And Clients

EP Global Communications, Inc . (EPGL), (the Company), (Pink Sheets: EPGL), (, the parent company of Exceptional Parent ( EP) magazine, and the EP Health Sciences Division are announcing to investors that on the eve of this year’s World Conference on Disabilities (WCD), the Muscle Pain Detection Device (MPDD) has been evaluated at two major US health institutions with several more expressing interest.

“Evaluation results are positive and we anticipate the FDA approved device, coupled with Dr. Norman Marcus’ treatment protocol, will help many millions of people impacted by pain,” said Joseph M. Valenzano Jr., CEO of EP Global Communications, Inc. “Use of the MPDD can provide clinicians with information about which muscles are causing back and neck pain and help reduce the associated staggering direct medical costs - 86 billion in 2005. It just needs more awareness, which we hope to help provide.”

This announcement comes as EP Global Communications is seeing unprecedented events and developments in its 40-year history. “We are excited about recent financial restructuring agreements as well as contracts and affiliations, including those with Web MD, the United States Marine Corps and soon the US Army, and a Keynote Address by Admiral Michael Mullen, Chairman of the Joint Chiefs of Staff, to kick off this year’s World Conference on Disabilities in Dallas, Texas,” explained Valenzano.

In addition, several online educational seminars will be broadcast live on the internet free of charge and investors, subscribers, and readers are encouraged to register and attend. Among the seminars to be broadcast is the presentation by Dr. Marcus to conference attendees and those viewing live online worldwide on how a muscle evaluation and treatment protocol utilizing the MPDD can reduce disability related to neck and back pain. Other seminars such as new treatment therapies for epilepsy, including surgical interventions, will also be available.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.65 -3.20%
FB $116.78 7.20%
GOOG $690.32 -2.20%
TSLA $247.70 -1.50%
YHOO $36.55 -1.10%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,074.51 -20.64 -0.99%
NASDAQ 4,805.6670 -57.4740 -1.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs